Publications by authors named "K G Lilley"

Cells have many protective mechanisms against background levels of ionizing radiation orchestrated by molecular changes in expression, post-translational modifications, and subcellular localization. Radiotherapeutic treatment in oncology attempts to overwhelm such mechanisms, but radioresistance is an ongoing challenge. Here, global subcellular proteomics combined with Bayesian modeling identified 544 differentially localized proteins in A549 cells upon 6 Gy X-ray exposure, revealing subcellular-specific changes of proteins involved in ferroptosis, an iron-dependent cell death, suggestive of potential radioresistance mechanisms.

View Article and Find Full Text PDF

Proteins are responsible for most intracellular functions, which they perform as part of higher-order molecular complexes, located within defined subcellular niches. Localization is both dynamic and context specific and mislocalization underlies a multitude of diseases. It is thus vital to be able to measure the components of higher-order protein complexes and their subcellular location dynamically in order to fully understand cell biological processes.

View Article and Find Full Text PDF

Australian Defence Force (ADF) personnel train and operate in malarious regions that include neighboring countries with high burden and species with latent hepatic parasites.1 We summarized longitudinal malaria case data, following a prior 10-year period review to 2007.2 Malaria case entries within the ADF Malaria and Infectious Diseases Institute (ADFMIDI)-managed Central Malaria Register (CMR) were examined.

View Article and Find Full Text PDF

Characterising RNA-protein interaction dynamics is fundamental to understand how bacteria respond to their environment. In this study, we have analysed the dynamics of 91% of the Escherichia coli expressed proteome and the RNA-interaction properties of 271 RNA-binding proteins (RBPs) at different growth phases. We find that 68% of RBPs differentially bind RNA across growth phases and characterise 17 previously unannotated proteins as bacterial RBPs including YfiF, a ncRNA-binding protein.

View Article and Find Full Text PDF
Article Synopsis
  • Many patients with inflammatory bowel disease (IBD) do not respond to traditional treatments, leading researchers to explore adalimumab (ADA) and vedolizumab (VDZ) as alternative therapies.
  • The study analyzed randomized controlled trials to compare the effectiveness of ADA and VDZ against placebo for treating moderate to severe Crohn's disease (CD) and ulcerative colitis (UC), focusing on clinical response, remission, and safety outcomes.
  • Results showed that both treatments were more effective than placebo for achieving remission and response in patients, with ADA being particularly more effective than VDZ for CD, but further studies on a larger scale are needed for better safety assessments.
View Article and Find Full Text PDF